114 related articles for article (PubMed ID: 19915831)
1. Characterization of modification enzyme NukM and engineering of a novel thioether bridge in lantibiotic nukacin ISK-1.
Shioya K; Harada Y; Nagao J; Nakayama J; Sonomoto K
Appl Microbiol Biotechnol; 2010 Apr; 86(3):891-9. PubMed ID: 19915831
[TBL] [Abstract][Full Text] [Related]
2. Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli.
Nagao J; Harada Y; Shioya K; Aso Y; Zendo T; Nakayama J; Sonomoto K
Biochem Biophys Res Commun; 2005 Oct; 336(2):507-13. PubMed ID: 16143300
[TBL] [Abstract][Full Text] [Related]
3. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
4. Engineering unusual amino acids into peptides using lantibiotic synthetase.
Nagao J; Shioya K; Harada Y; Okuda K; Zendo T; Nakayama J; Sonomoto K
Methods Mol Biol; 2011; 705():225-36. PubMed ID: 21125389
[TBL] [Abstract][Full Text] [Related]
5. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
[TBL] [Abstract][Full Text] [Related]
6. In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.
Shimafuji C; Noguchi M; Nishie M; Nagao J; Shioya K; Zendo T; Nakayama J; Sonomoto K
J Biosci Bioeng; 2015 Dec; 120(6):624-9. PubMed ID: 25971839
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.
Aso Y; Sashihara T; Nagao J; Kanemasa Y; Koga H; Hashimoto T; Higuchi T; Adachi A; Nomiyama H; Ishizaki A; Nakayama J; Sonomoto K
Biosci Biotechnol Biochem; 2004 Aug; 68(8):1663-71. PubMed ID: 15322349
[TBL] [Abstract][Full Text] [Related]
8. A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure.
Sashihara T; Kimura H; Higuchi T; Adachi A; Matsusaki H; Sonomoto K; Ishizaki A
Biosci Biotechnol Biochem; 2000 Nov; 64(11):2420-8. PubMed ID: 11193411
[TBL] [Abstract][Full Text] [Related]
9. Localization and interaction of the biosynthetic proteins for the lantibiotic, Nukacin ISK-1.
Nagao J; Aso Y; Sashihara T; Shioya K; Adachi A; Nakayama J; Sonomoto K
Biosci Biotechnol Biochem; 2005 Jul; 69(7):1341-7. PubMed ID: 16041140
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of essential and variable residues of nukacin ISK-1 by NNK scanning.
Islam MR; Shioya K; Nagao J; Nishie M; Jikuya H; Zendo T; Nakayama J; Sonomoto K
Mol Microbiol; 2009 Jun; 72(6):1438-47. PubMed ID: 19432794
[TBL] [Abstract][Full Text] [Related]
11. Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production.
Chatterjee C; Miller LM; Leung YL; Xie L; Yi M; Kelleher NL; van der Donk WA
J Am Chem Soc; 2005 Nov; 127(44):15332-3. PubMed ID: 16262372
[TBL] [Abstract][Full Text] [Related]
12. Lantibiotic transporter requires cooperative functioning of the peptidase domain and the ATP binding domain.
Nishie M; Sasaki M; Nagao J; Zendo T; Nakayama J; Sonomoto K
J Biol Chem; 2011 Apr; 286(13):11163-9. PubMed ID: 21303905
[TBL] [Abstract][Full Text] [Related]
13. Binding specificity of the lantibiotic-binding immunity protein NukH.
Okuda K; Yanagihara S; Shioya K; Harada Y; Nagao J; Aso Y; Zendo T; Nakayama J; Sonomoto K
Appl Environ Microbiol; 2008 Dec; 74(24):7613-9. PubMed ID: 18978082
[TBL] [Abstract][Full Text] [Related]
14. Nukacin 3299, a lantibiotic produced by Staphylococcus simulans 3299 identical to nukacin ISK-1.
Ceotto H; Holo H; da Costa KF; Nascimento Jdos S; Salehian Z; Nes IF; Bastos Mdo C
Vet Microbiol; 2010 Nov; 146(1-2):124-31. PubMed ID: 20627619
[TBL] [Abstract][Full Text] [Related]
15. Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.
Aso Y; Nagao J; Koga H; Okuda K; Kanemasa Y; Sashihara T; Nakayama J; Sonomoto K
J Biosci Bioeng; 2004; 98(6):429-36. PubMed ID: 16233732
[TBL] [Abstract][Full Text] [Related]
16. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
[TBL] [Abstract][Full Text] [Related]
17. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
[TBL] [Abstract][Full Text] [Related]
18. Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity.
Xie L; Miller LM; Chatterjee C; Averin O; Kelleher NL; van der Donk WA
Science; 2004 Jan; 303(5658):679-81. PubMed ID: 14752162
[TBL] [Abstract][Full Text] [Related]
19. A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1.
Aso Y; Okuda K; Nagao J; Kanemasa Y; Thi Bich Phuong N; Koga H; Shioya K; Sashihara T; Nakayama J; Sonomoto K
Biosci Biotechnol Biochem; 2005 Jul; 69(7):1403-10. PubMed ID: 16041148
[TBL] [Abstract][Full Text] [Related]
20. Characterization of functional domains of lantibiotic-binding immunity protein, NukH, from Staphylococcus warneri ISK-1.
Okuda K; Aso Y; Nagao J; Shioya K; Kanemasa Y; Nakayama J; Sonomoto K
FEMS Microbiol Lett; 2005 Sep; 250(1):19-25. PubMed ID: 16009508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
